Dr. Wael L. Hamade, MD

Dr. Hamade practices at Riverside University Medical Center in Moreno Valley, California.

Dr. Hamade's NPI, 1295924710, was assigned on October 22, 2007. Dr. Hamade graduated from Kaunas Medical Institute in 1999. Dr. Hamade holds California license A100880.

Dr. Hamade's primary practice is Riverside University Medical Center, at 26520 Cactus Ave, Moreno Valley, CA 92555 in Riverside County. The practice phone is (951) 486-4458.

Dr. Hamade's primary practice is Riverside University Medical Center in Moreno Valley, California. Dr. Hamade is also affiliated with Riverside University Health System - Medical Center. The medical group on file is Indio Community Health Center. Dmand AI also links Dr. Hamade to 1 more home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hamade practices, 2 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Hamade's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Hamade is board certified in family medicine by the American Board of Family Medicine. Dmand AI has Dr. Hamade's licenses on file in 2 states: California and Washington.

Dmand AI lists alzheimer's disease, atrial fibrillation and flutter, chronic anemia, chronic diabetes, chronic hypertension, chronic inflammatory bowel disease (IBD), chronic kidney disease and chronic nasal allergies among the conditions Dr. Hamade treats.

CMS data shows 665 Medicare services from Dr. Hamade across 4 procedure codes in 2024, for 432 Medicare patients. Medicare paid $68,708 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 432 Medicare patients who saw Dr. Hamade in 2024. The largest group is 75 to 84, with 159 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 69% are also on Medicaid. Their average risk score is 2.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hamade's median patient age at 78, with 60% women.

In 2024, Dr. Hamade wrote 449 Medicare Part D claims for 53 patients. 76% of them were for generic drugs. CMS names the drug for 215 of them, across 11 drugs with 11 or more claims each, at $7,429 in total drug cost. In 2023, CMS named 605 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Hamade for performance year 2024, reported as part of a group.

CMS Open Payments shows 1 general payment to Dr. Hamade from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $73.

Dr. Hamade graduated from Kaunas Medical Institute in 1999.

Dr. Hamade is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.